Steven C Katz Selected Research

Tumor Biomarkers (Tumor Markers)

1/2020

HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven C Katz Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 03/2005
15	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2006
4	Adenocarcinoma 01/2023 - 07/2017
4	Hematologic Neoplasms (Hematological Malignancy) 03/2022 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 07/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 10/2011
2	Inflammation (Inflammations) 10/2016 - 10/2013
1	Cytokine Release Syndrome 12/2020
1	COVID-19 12/2020
1	Ascites 08/2018
1	Hepatitis 10/2016
1	Liver Diseases (Liver Disease) 10/2016
1	Wounds and Injuries (Trauma) 05/2015
1	Incisional Hernia 05/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2013
1	Lymphoma (Lymphomas) 10/2011
1	Splenic Infarction 09/2011
1	Fibrosis (Cirrhosis) 08/2011
1	Infections 08/2011
1	Cholestasis 08/2011
1	Obstructive Jaundice (Cholestatic Jaundice) 08/2011
1	Pain (Aches) 04/2007
1	Melanoma (Melanoma, Malignant) 11/2006
1	Adenoma (Adenomas) 02/2003
1	Primary Hyperparathyroidism 02/2003

Drug/Important Bio-Agent (IBA)

8	Chimeric Antigen ReceptorsIBA 03/2022 - 07/2015
5	CytokinesIBA 01/2023 - 03/2005
2	cyclopropapyrroloindoleIBA 12/2022 - 07/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2022 - 10/2018
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 10/2013
2	Carcinoembryonic AntigenIBA 01/2020 - 08/2018
2	AntigensIBA 08/2018 - 05/2006
1	Toll-Like Receptor 9IBA 01/2023
1	CPG-oligonucleotideIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	B-Cell Maturation AntigenIBA 03/2022
1	AntibodiesIBA 03/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2022
1	CTLA-4 AntigenIBA 03/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	ProteomeIBA 09/2021
1	tocilizumab (atlizumab)FDA Link 12/2020
1	siltuximabIBA 12/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	napabucasinIBA 01/2019
1	statticIBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2018
1	VaccinesIBA 08/2018
1	Epithelial Cell Adhesion MoleculeIBA 08/2018
1	catumaxomabIBA 08/2018
1	Granzymes (Granzyme)IBA 01/2017
1	PerforinIBA 01/2017
1	IntegrinsIBA 01/2017
1	dectin 1IBA 10/2016
1	LigandsIBA 10/2016
1	C-Type Lectins (C-Type Lectin)IBA 10/2016
1	NitritesIBA 10/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2015
1	Biocompatible Materials (Biomaterials)IBA 05/2015
1	Imatinib Mesylate (Gleevec)FDA Link 02/2013
1	Sorafenib (BAY 43-9006)FDA Link 11/2012
1	Dihydrotachysterol (AT 10)IBA 10/2011
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2009
1	Interleukin-18 (Interleukin 18)IBA 11/2006
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 02/2003
1	Parathyroid Hormone (Parathormone)IBA 02/2003

Therapy/Procedure

16	Immunotherapy 01/2023 - 02/2013
11	Therapeutics 01/2023 - 04/2013
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022 - 01/2020
3	Radiotherapy 03/2022 - 10/2011
2	Drug Therapy (Chemotherapy) 03/2022 - 05/2015
2	Ligation 10/2016 - 08/2011
1	Catheters 01/2024
1	Radiofrequency Ablation 12/2012
1	Splenectomy 09/2011
1	Pancreatectomy 09/2011
1	Thyroidectomy 10/2009
1	Cholecystectomy 04/2007
1	Minimally Invasive Surgical Procedures 02/2003
1	Thoracotomy 02/2003
1	Parathyroidectomy 02/2003